{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T02:44:56Z","timestamp":1772246696091,"version":"3.50.1"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T00:00:00Z","timestamp":1639612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004385","name":"Universiteit Gent","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Hepatitis C virus (HCV) is highly variable and transmits through infected blood to establish a chronic liver infection in the majority of patients. Our knowledge on the infectivity of clinical HCV strains is hampered by the lack of\n                    <jats:italic>in vitro<\/jats:italic>\n                    cell culture systems that support efficient viral replication. We and others have reported that HCV can associate with and infect immune cells and may thereby evade host immune surveillance and elimination. To evaluate whether B cells play a role in HCV transmission, we assessed the ability of B cells and sera from recent (&amp;lt;2 years) or chronic (\u2265 2 years) HCV patients to infect humanized liver chimeric mice. HCV was transmitted by B cells from chronic infected patients whereas the sera were non-infectious. In contrast, B cells from recently infected patients failed to transmit HCV to the mice, whereas all serum samples were infectious. We observed an association between circulating anti-glycoprotein E1E2 antibodies and B cell HCV transmission. Taken together, our studies provide evidence for HCV transmission by B cells, findings that have clinical implications for prophylactic and therapeutic antibody-based vaccine design.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2021.775098","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T13:55:08Z","timestamp":1639662908000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["A Role for B Cells to Transmit Hepatitis C Virus Infection"],"prefix":"10.3389","volume":"12","author":[{"given":"Isabelle","family":"Desombere","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Freya","family":"Van Houtte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Farhoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lieven","family":"Verhoye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Buysschaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Gijbels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibyl","family":"Couvent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilfried","family":"Swinnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Van Vlierberghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Elewaut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Magri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zania","family":"Stamataki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Meuleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane A","family":"McKeating","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert","family":"Leroux-Roels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,16]]},"reference":[{"key":"B1","unstructured":"WHOGlobal Hepatitis Report2017"},{"key":"B2","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nrd4050","article-title":"Novel Therapies for Hepatitis C \u2014 One Pill Fits All","volume":"12","author":"Manns","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13514","article-title":"Review Article: Safety and Tolerability of Direct-Acting Anti-Viral Agents in the New Era of Hepatitis C Therapy","volume":"43","author":"Banerjee","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12422","article-title":"Interferon-Free, Direct-Acting Antiviral Therapy for Chronic Hepatitis C","volume":"22","author":"Gutierrez","year":"2015","journal-title":"J Viral Hepatitis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32320-7","article-title":"Hepatitis C","volume":"394","author":"Spearman","year":"2019","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1053\/j.gastro.2017.06.012","article-title":"Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents","volume":"153","author":"Kanwal","year":"2017","journal-title":"Gastroenterology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.10.017","article-title":"Risk of Cirrhosis-Related Complications in Patients With Advanced Fibrosis Following Hepatitis C Virus Eradication","volume":"66","author":"van der Meer","year":"2017","journal-title":"J Hepatol"},{"key":"B8","unstructured":"Combating Hepatitis B and C To Reach Elimination By 2030 May 2016 Advocacy Brief2016"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/cld.753","article-title":"Hepatitis C Vaccine Development in the Era of Direct-Acting Antivirals","volume":"12","author":"McConnell","year":"2018","journal-title":"Clin Liver Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2017.03.014","article-title":"Designing an HCV Vaccine: A Unique Convergence of Prevention and Therapy","volume":"23","author":"Walker","year":"2017","journal-title":"Curr Opin Virol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1053\/j.gastro.2018.10.048","article-title":"What Is Needed to Eliminate Hepatitis B Virus and Hepatitis C Virus as Global Health Threats","volume":"156","author":"Ward","year":"2019","journal-title":"Gastroenterology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1297925","article-title":"New Insights Into the HCV Quasispecies and Compartmentalization","volume":"31","author":"Farci","year":"2011","journal-title":"Semin Liver Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.12.008","article-title":"Hepatitis C Virus Continuously Escapes From Neutralizing Antibody and T-Cell Responses During Chronic Infection In Vivo","volume":"132","author":"Hahn","year":"2007","journal-title":"Gastroenterology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1126\/science.288.5464.339","article-title":"The\u00a0Outcome of Acute Hepatitis C Predicted by the Evolution of the Viral\u00a0Quasispecies","volume":"288","author":"Farci","year":"2000","journal-title":"Science"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70965-X","article-title":"Resistance to Hepatitis C Virus: Potential Genetic and Immunological Determinants","volume":"15","author":"Mina","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.08.060","article-title":"Approaches, Progress, and Challenges to Hepatitis C Vaccine Development","volume":"156","author":"Bailey","year":"2019","journal-title":"Gastroenterology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1086\/428578","article-title":"Prospective Evaluation of Community-Acquired Acute-Phase Hepatitis C Virus Infection","volume":"40","author":"Cox","year":"2005","journal-title":"Clin Infect Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27013","article-title":"Clearance of Hepatitis C Infection Is Associated With the Early Appearance of Broad Neutralizing Antibody Responses","volume":"59","author":"Osburn","year":"2014","journal-title":"Hepatology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0607026104","article-title":"Rapid Induction of Virus-Neutralizing Antibodies and Viral Clearance in a Single-Source Outbreak of Hepatitis C","volume":"104","author":"Pestka","year":"2007","journal-title":"PNAS"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/nm1698","article-title":"Broadly Neutralizing Antibodies Protect Against Hepatitis C Virus Quasispecies Challenge","volume":"14","author":"Law","year":"2008","journal-title":"Nat Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir399","article-title":"Immunization of Human Volunteers With Hepatitis C Virus Envelope Glycoproteins Elicits Antibodies That Cross-Neutralize Heterologous Virus Strains","volume":"204","author":"Stamataki","year":"2011","journal-title":"J Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.antiviral.2017.10.015","article-title":"A Novel Neutralizing Human Monoclonal Antibody Broadly Abrogates Hepatitis C Virus Infection In Vitro and In Vivo","volume":"148","author":"Desombere","year":"2017","journal-title":"Antiviral Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2014.02.013","article-title":"The Past, Present and Future of Neutralizing Antibodies for Hepatitis C Virus","volume":"105","author":"Ball","year":"2014","journal-title":"Antiviral Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02692","article-title":"Designing a B Cell-Based Vaccine Against a Highly Variable Hepatitis C Virus","volume":"8","author":"Fuerst","year":"2018","journal-title":"Front Microbiol"},{"key":"B25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-3-642-27340-7_2","article-title":"Cell Culture Systems for Hepatitis C Virus","volume-title":"Hepatitis C Virus: From Molecular Virology to Antiviral Therapy Current Topics in Microbiology and Immunology","author":"Steinmann","year":"2013"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nm1268","article-title":"Production of Infectious Hepatitis C Virus in Tissue Culture From a Cloned Viral Genome","volume":"11","author":"Wakita","year":"2005","journal-title":"Nat Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1126\/science.1114016","article-title":"Complete Replication of Hepatitis C Virus in Cell Culture","volume":"309","author":"Lindenbach","year":"2005","journal-title":"Science"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2018.00049","article-title":"HCV Extrahepatic Manifestations","volume":"7","author":"Kuna","year":"2019","journal-title":"J\u00a0Clin Transl Hepatol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/hep.21283","article-title":"Extrahepatic Replication of HCV: Insights Into Clinical Manifestations and Biological Consequences","volume":"44","author":"Blackard","year":"2006","journal-title":"Hepatology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29845","article-title":"Prevalence and Association of Hepatitis C Virus Infection With Different Types of Lymphoma","volume":"138","author":"Iqbal","year":"2016","journal-title":"Int J Cancer"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23562","article-title":"Antiviral Therapy of Symptomatic HCV-Associated Mixed Cryoglobulinemia: Meta-Analysis of Clinical Studies","volume":"85","author":"Fabrizi","year":"2013","journal-title":"J\u00a0Med Virol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14119","article-title":"Hepatitis C Virus Infection and Non-Hepatocellular Malignancies in the DAA Era: A Systematic Review and Meta-Analysis","volume":"39","author":"Masarone","year":"2019","journal-title":"Liver Int"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12518","article-title":"The Anti-Lymphoma Activity of Antiviral Therapy in HCV-Associated B-Cell Non-Hodgkin Lymphomas: A Meta-Analysis","volume":"23","author":"Peveling-Oberhag","year":"2016","journal-title":"J Viral Hepat"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.12.039","article-title":"Productive Replication of Hepatitis C Virus in Perihepatic Lymph Nodes In Vivo: Implications of HCV Lymphotropism","volume":"130","author":"Pal","year":"2006","journal-title":"Gastroenterology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1159\/000317690","article-title":"Peripheral B Cells May Serve as a Reservoir for Persistent Hepatitis C Virus Infection","volume":"2","author":"Ito","year":"2010","journal-title":"JIN"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-8-346","article-title":"Human Cell Types Important for Hepatitis C Virus Replication In Vivo and In Vitro. Old Assertions and Current Evidence","volume":"8","author":"Revie","year":"2011","journal-title":"Virol J"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.12.011","article-title":"Hepatitis C Virus Replicates in the Same Immune Cell Subsets in Chronic Hepatitis C and Occult Infection","volume":"134","author":"Pham","year":"2008","journal-title":"Gastroenterology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2015.364","article-title":"Hepatitis C Virus Upregulates B-Cell Receptor Signaling: A Novel Mechanism for HCV-Associated B-Cell Lymphoproliferative Disorders","volume":"35","author":"Dai","year":"2016","journal-title":"Oncogene"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-05-158824","article-title":"Hepatitis C Virus Association With Peripheral Blood B Lymphocytes Potentiates Viral Infection of Liver-Derived Hepatoma Cells","volume":"113","author":"Stamataki","year":"2009","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1086\/651579","article-title":"Challenge Pools of Hepatitis C Virus Genotypes 1\u20136 Prototype Strains: Replication Fitness and Pathogenicity in Chimpanzees and Human Liver-Chimeric Mouse Models","volume":"201","author":"Bukh","year":"2010","journal-title":"J Infect Dis"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20657","article-title":"Morphological and Biochemical Characterization of a Human Liver in a uPA-SCID Mouse Chimera","volume":"41","author":"Meuleman","year":"2005","journal-title":"Hepatology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/90968","article-title":"Hepatitis C Virus Replication in Mice With Chimeric Human Livers","volume":"7","author":"Mercer","year":"2001","journal-title":"Nat Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2006.10.013","article-title":"Inhibition of Replication of Primary HIV-1 Isolates in huPBL-NOD\/Scid Mice by Antibodies From HIV-1 Infected Patients","volume":"75","author":"Steyaert","year":"2007","journal-title":"Antiviral Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(03)01388-3","article-title":"A Simple and Rapid Method to Determine the Zygosity of uPA-Transgenic SCID Mice","volume":"308","author":"Meuleman","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20090766","article-title":"Viral Entry and Escape From Antibody-Mediated Neutralization Influence Hepatitis C Virus Reinfection in Liver Transplantation","volume":"207","author":"Fafi-Kremer","year":"2010","journal-title":"J Exp Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/msn067","article-title":"An Improved General Amino Acid Replacement Matrix","volume":"25","author":"Le","year":"2008","journal-title":"Mol Biol Evol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1093\/sysbio\/syq010","article-title":"New Algorithms and Methods to Estimate Maximum-Likelihood Phylogenies: Assessing the Performance of PhyML 3.0","volume":"59","author":"Guindon","year":"2010","journal-title":"Syst Biol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1385\/0-89603-521-2:471","article-title":"Strand-Specific Rtth RT-PCR for the Analysis of HCV Replication","volume":"19","author":"Lanford","year":"1999","journal-title":"Methods Mol Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25921","article-title":"Investigation of Residual Hepatitis C Virus in Presumed Recovered Subjects","volume":"57","author":"Fujiwara","year":"2013","journal-title":"Hepatology"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20518","article-title":"Persistence of Hepatitis C Virus in Patients Successfully Treated for Chronic Hepatitis C","volume":"41","author":"Radkowski","year":"2005","journal-title":"Hepatology"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0832180100","article-title":"Hepatitis C Virus Glycoproteins Mediate pH-Dependent Cell Entry of Pseudotyped Retroviral Particles","volume":"100","author":"Hsu","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0402458101","article-title":"Neutralizing Antibodies to Hepatitis C Virus (HCV) in Immune Globulins Derived From Anti-HCV-Positive Plasma","volume":"101","author":"Yu","year":"2004","journal-title":"PNAS"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.67.4.1953-1958.1993","article-title":"Equilibrium Centrifugation Studies of Hepatitis C Virus: Evidence for Circulating Immune Complexes","author":"Hijikata","year":"1993","journal-title":"J Virol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2013.00212","article-title":"Hepatitis C Virus Infection and Related Liver Disease: The Quest for the Best Animal Model","volume":"4","author":"Mailly","year":"2013","journal-title":"Front Microbiol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.26.15394","article-title":"Prevention of Hepatitis C Virus Infection in Chimpanzees by Hyperimmune Serum Against the Hypervariable Region 1 of the Envelope 2 Protein","volume":"93","author":"Farci","year":"1996","journal-title":"PNAS"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/nature14899","article-title":"SEC14L2 Enables Pan-Genotype HCV Replication in Cell Culture","volume":"524","author":"Saeed","year":"2015","journal-title":"Nature"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.000085","article-title":"Permissivity of Primary Hepatocytes and Hepatoma Cell Lines to Support Hepatitis C Virus Infection","volume":"96","author":"Wilson","year":"2015","journal-title":"J Gen Virol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-8976-8_32","article-title":"Mice With Chimeric Human Livers and Their Applications","volume":"1911","author":"Douglas","year":"2019","journal-title":"Methods Mol Biol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28428","article-title":"Monoclonal Anti-Envelope Antibody AP33 Protects Humanized Mice Against a Patient-Derived Hepatitis C Virus Challenge","volume":"63","author":"Desombere","year":"2016","journal-title":"Hepatology"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1053\/j.gastro.2019.11.282","article-title":"Antibody Responses to Immunization With HCV Envelope Glycoproteins as a Baseline for B-Cell-Based Vaccine Development","volume":"158","author":"Chen","year":"2020","journal-title":"Gastroenterology"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.1.13","article-title":"Human IgM+CD27+ B Cells: Memory B Cells or \u201cMemory\u201d B Cells","volume":"179","author":"Tangye","year":"2007","journal-title":"J Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1416276112","article-title":"Functional Capacities of Human IgM Memory B Cells in Early Inflammatory Responses and Secondary Germinal Center Reactions","volume":"112","author":"Seifert","year":"2015","journal-title":"PNAS"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/nri3822","article-title":"Making Sense in Humans","volume":"15","author":"Kugelberg","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2017.4682","article-title":"Abnormal Phenotypic Features of IgM+B Cell Subsets in Patients With Chronic Hepatitis C Virus Infection","volume":"14","author":"Kong","year":"2017","journal-title":"Exp Ther Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-09-805762","article-title":"Biased IGH VDJ Gene Repertoire and Clonal Expansions in B Cells of Chronically Hepatitis C Virus\u2013Infected Individuals","volume":"131","author":"Tucci","year":"2018","journal-title":"Blood"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22763","article-title":"Chemokines in the Immunopathogenesis of Hepatitis C Infection","volume":"49","author":"Heydtmann","year":"2009","journal-title":"Hepatology"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24763","article-title":"Activation of Chemokine and Inflammatory Cytokine Response in Hepatitis C Virus\u2013Infected Hepatocytes Depends on Toll-Like Receptor 3 Sensing of Hepatitis C Virus Double-Stranded RNA Intermediates","volume":"55","author":"Li","year":"2012","journal-title":"Hepatology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jhep.2010.10.016","article-title":"Enhanced B-Cell Differentiation and Reduced Proliferative Capacity in Chronic Hepatitis C and Chronic Hepatitis B Virus Infections","volume":"55","author":"Oliviero","year":"2011","journal-title":"J Hepatol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2009.0047","article-title":"Possible Recruitment of Peripheral Blood CXCR3+ CD27+ CD19+ B Cells to the Liver of Chronic Hepatitis C Patients","volume":"30","author":"Mizuochi","year":"2010","journal-title":"J Interferon Cytokine Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.775098\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T13:55:19Z","timestamp":1639662919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.775098\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,16]]},"references-count":69,"alternative-id":["10.3389\/fimmu.2021.775098"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.775098","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-41273\/v1","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,16]]},"article-number":"775098"}}